These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10958384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease.
    Verhoeven GT, Garrelds IM, Hoogsteden HC, Zijlstra FJ.
    Mediators Inflamm; 2001 Feb; 10(1):21-6. PubMed ID: 11324900
    [Abstract] [Full Text] [Related]

  • 3. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients.
    Zheng L, Walters EH, Wang N, Whitford H, Orsida B, Levvey B, Bailey M, Williams TJ, Snell GI.
    J Heart Lung Transplant; 2004 Apr; 23(4):446-55. PubMed ID: 15063404
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW, Wen Y, Johns DP, Williams TJ, Ward C, Walters EH.
    Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
    [Abstract] [Full Text] [Related]

  • 6. Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice.
    Chu HW, Campbell JA, Rino JG, Harbeck RJ, Martin RJ.
    J Infect Dis; 2004 Mar 15; 189(6):1119-27. PubMed ID: 14999617
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oxidative stress indices in COPD--Broncho-alveolar lavage and salivary analysis.
    Yigla M, Berkovich Y, Nagler RM.
    Arch Oral Biol; 2007 Jan 15; 52(1):36-43. PubMed ID: 17092480
    [Abstract] [Full Text] [Related]

  • 9. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.
    Thorax; 2005 Jun 15; 60(6):480-7. PubMed ID: 15923248
    [Abstract] [Full Text] [Related]

  • 10. Enhanced reactive oxygen species metabolism of air space cells in hypersensitivity pneumonitis.
    Calhoun WJ.
    J Lab Clin Med; 1991 Jun 15; 117(6):443-52. PubMed ID: 1646269
    [Abstract] [Full Text] [Related]

  • 11. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
    Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ.
    Am J Respir Crit Care Med; 1999 Nov 15; 160(5 Pt 1):1635-9. PubMed ID: 10556133
    [Abstract] [Full Text] [Related]

  • 12. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E, Ekstrand-Hammarström B, Pourazar J, Behndig AF, Bucht A, Blomberg A.
    COPD; 2009 Apr 15; 6(2):112-20. PubMed ID: 19378224
    [Abstract] [Full Text] [Related]

  • 13. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD.
    Thompson WH, Carvalho P, Souza JP, Charan NB.
    Lung; 2002 Apr 15; 180(4):191-201. PubMed ID: 12391509
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity in cell recovery and superoxide production in buoyant, density-defined subpopulations of human alveolar macrophages from healthy volunteers and sarcoidosis patients.
    Calhoun WJ, Salisbury SM.
    J Lab Clin Med; 1989 Dec 15; 114(6):682-90. PubMed ID: 2556490
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease.
    Hodge SJ, Hodge GL, Holmes M, Reynolds PN.
    Cytometry B Clin Cytom; 2004 Sep 15; 61(1):27-34. PubMed ID: 15351979
    [Abstract] [Full Text] [Related]

  • 16. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone.
    Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro A, D'Ippolito R, Baraldo S, Testi R, Saetta M, Olivieri D.
    Am J Respir Crit Care Med; 2003 Mar 01; 167(5):751-7. PubMed ID: 12468439
    [Abstract] [Full Text] [Related]

  • 17. Are high-dose inhaled steroids effective for chronic obstructive pulmonary disease (COPD)?
    Rosenbaum D, Merenstein D, McCormally T.
    J Fam Pract; 2000 Sep 01; 49(9):781-2. PubMed ID: 11032197
    [No Abstract] [Full Text] [Related]

  • 18. Vanadium-induced apoptosis and pulmonary inflammation in mice: Role of reactive oxygen species.
    Wang L, Medan D, Mercer R, Overmiller D, Leornard S, Castranova V, Shi X, Ding M, Huang C, Rojanasakul Y.
    J Cell Physiol; 2003 Apr 01; 195(1):99-107. PubMed ID: 12599213
    [Abstract] [Full Text] [Related]

  • 19. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
    van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C.
    Am J Respir Crit Care Med; 2002 Nov 15; 166(10):1358-63. PubMed ID: 12406823
    [Abstract] [Full Text] [Related]

  • 20. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H, Yamase H.
    Arerugi; 2003 Jan 15; 52(1):31-8. PubMed ID: 12598720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.